- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 529087, 7 pages
Comparison of New Technology Integrated and Nonintegrated Arterial Filters Used in Cardiopulmonary Bypass Surgery: A Randomized, Prospective, and Single Blind Study
1Department of Cardiovascular Surgery, Marmara University Medical Faculty, 34668 Istanbul, Turkey
2Department of Medical Biochemistry, Marmara University Medical Faculty, 34668 Istanbul, Turkey
Received 6 August 2013; Accepted 26 September 2013
Academic Editor: Paul Evans
Copyright © 2013 Özgür Gürsu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- G. Tagarakis, M. E. Daskalopoulos, and N. B. Tsilimingas, “Avoiding cardiopulmonary bypass does not protect against neuropsychiatric complications in elderly patients,” Interactive Cardiovascular and Thoracic Surgery, vol. 12, no. 3, article 439, 2011.
- R. Lorusso, G. de Cicco, P. Totaro, and S. Gelsomino, “Effects of phosphorylcholine coating on extracorporeal circulation management and postoperative outcome: a double-blind randomized study,” Interactive Cardiovascular and Thoracic Surgery, vol. 8, no. 1, pp. 7–11, 2009.
- F. Qiu, S. Peng, A. Kunselman, and A. Ündar, “Evaluation of capiox FX05 oxygenator with an integrated arterial filter on trapping gaseous microemboli and pressure drop with open and closed purge line,” Artificial Organs, vol. 34, no. 11, pp. 1053–1057, 2010.
- F. Biancari and R. Rimpiläinen, “Meta-analysis of randomised trials comparing the effectiveness of miniaturised versus conventional cardiopulmonary bypass in adult cardiac surgery,” Heart, vol. 95, no. 12, pp. 964–969, 2009.
- L. H. Edmunds Jr., “Inflammatory response to cardiopulmonary bypass,” Annals of Thoracic Surgery, vol. 66, no. 5, supplement, pp. S12–S16, 1998.
- W. Martin, R. Carter, A. Tweddel et al., “Respiratory dysfunction and white cell activation following cardiopulmonary bypass: comparison of membrane and bubble oxygenators,” European Journal of Cardio-Thoracic Surgery, vol. 10, no. 9, pp. 774–783, 1996.
- M. Rothenburger, F. Trösch, A. Markewitz et al., “Leukocyte activation and phagocytotic activity in cardiac surgery and infection,” Cardiovascular Surgery, vol. 10, no. 5, pp. 470–475, 2002.
- J. Cremer, M. Martin, H. Redl et al., “Systemic inflammatory response syndrome after cardiac operations,” Annals of Thoracic Surgery, vol. 61, no. 6, pp. 1714–1720, 1996.
- Y. Fromes, D. Gaillard, O. Ponzio et al., “Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation,” European Journal of Cardio-Thoracic Surgery, vol. 22, no. 4, pp. 527–533, 2002.
- J. Wippermann, J. M. Albes, M. Hartrumpf et al., “Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system,” European Journal of Cardio-Thoracic Surgery, vol. 28, no. 1, pp. 127–132, 2005.
- G. J. Myers, K. Gardiner, S. N. Ditmore et al., “Clinical evaluation of the sorin synthesis oxygenator with integrated arterial filter,” Journal of Extra-Corporeal Technology, vol. 37, no. 2, pp. 201–206, 2005.
- D. E. Chenoweth, S. W. Cooper, T. E. Hugli, R. W. Stewart, E. H. Blackstone, and J. W. Kirklin, “Complement activation during cardiopulmonary bypass. Evidence for generation of C3a and C5a anaphylatoxins,” The New England Journal of Medicine, vol. 304, no. 9, pp. 497–503, 1981.
- D. S. Morse, D. Adams, and B. Magnani, “Platelet and neutrophil activation during cardiac surgical procedures: impact of cardiopulmonary bypass,” Annals of Thoracic Surgery, vol. 65, no. 3, pp. 691–695, 1998.
- P. H. M. Kuijper, H. I. G. Torres, J. W. J. Lammers, J. J. Sixma, L. Koenderman, and J. J. Zwaginga, “Platelet and fibrin deposition at the damaged vessel wall: cooperative substrates for neutrophil adhesion under flow conditions,” Blood, vol. 89, no. 1, pp. 166–175, 1997.
- C. S. Rinder, J. L. Bonan, H. M. Rinder, J. Mathew, R. Hines, and B. R. Smith, “Cardiopulmonary bypass induces leukocyte-platelet adhesion,” Blood, vol. 79, no. 5, pp. 1201–1205, 1992.
- R. H. Habib, A. Zacharias, T. A. Schwann, C. J. Riordan, S. J. Durham, and A. Shah, “Adverse effects of low hematocrit during, cardiopulmonary bypass in the adult: should current practice be changed?” Journal of Thoracic and Cardiovascular Surgery, vol. 125, no. 6, pp. 1438–1450, 2003.
- W. C. Fang, R. E. Helm, K. H. Krieger et al., “Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery,” Circulation, vol. 96, no. 9, supplement, pp. II194–II199, 1997.
- N. Curtis, H. A. Vohra, and S. K. Ohri, “Mini extracorporeal circuit cardiopulmonary bypass system: a review,” Perfusion, vol. 25, no. 3, pp. 115–124, 2010.
- W. B. Gerritsen, W. J. van Boven, R. M. Wesselink et al., “Significant reduction in blood loss in patients undergoing minimal extracorporeal circulation,” Transfusion Medicine, vol. 16, no. 5, pp. 329–334, 2006.
- J. P. Remadi, Z. Rakotoarivelo, P. Marticho, and A. Benamar, “Prospective randomized study comparing coronary artery bypass grafting with the new mini-extracorporeal circulation Jostra System or with a standard cardiopulmonary bypass,” The American Heart Journal, vol. 151, no. 1, pp. 198.e1–198.e7, 2006.
- M. Stalder, E. Gygax, F. F. Immer, L. Englberger, H. Tevaearai, and T. P. Carrel, “Minimized cardiopulmonary bypass combined with a smart suction device: the future of cardiopulmonary bypass?” The Heart Surgery Forum, vol. 10, no. 3, pp. E235–E238, 2007.
- E. E. Ševerdija, J. H. Heijmans, M. Theunissen, J. G. Maessen, P. H. Roekaerts, and P. W. Weerwind, “Retrograde autologous priming reduces transfusion requirements in coronary artery bypass surgery,” Perfusion, vol. 26, no. 4, pp. 315–321, 2011.
- K. Ak, S. Isbir, A. Tekeli et al., “Presence of lipoprotein lipase S447X stop codon affects the magnitude of interleukin 8 release after cardiac surgery with cardiopulmonary bypass,” Journal of Thoracic and Cardiovascular Surgery, vol. 134, no. 2, pp. 477–483, 2007.
- B. Delannoy, M. L. Guye, D. H. Slaiman, J. J. Lehot, and M. Cannesson, “Effect of cardiopulmonary bypass on activated partial thromboplastin time waveform analysis, serum procalcitonin and C-reactive protein concentrations,” Critical Care, vol. 13, no. 6, article R180, 2009.
- O. Alataş, O. Çolak, B. Büyükkidan, O. Portakal, and B. Tanriverdi, “Soluble interleukin-2 receptor and interleukin-8 plasma levels during and after cardiopulmonary bypass: correlations with creatine kinase and creatine kinase MB,” Clinical and Experimental Medicine, vol. 1, no. 1, pp. 13–18, 2001.